NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc.
After a deep pullback in August and September, Amphastar is coming back in a big way. Following its early-November earnings report, the stock is up more than 20% in the last few weeks. It has reclaimed all its moving averages and is now consolidation with a pivot at $58.

Volume has dried up nicely during this consolidation which is typically a sign the stock is becoming harder to buy and getting concentrated into strong institutional hands.

One might consider buying on a high-volume move above $58.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。